Literature DB >> 9755793

Hepatitis B viruses and cancerogenesis.

M A Buendia1.   

Abstract

Hepatitis B virus (HBV) is a small, enveloped DNA virus which primarily infects liver cells and causes acute and persistent liver disease. Chronic HBV infection, frequently associated with cirrhosis and eventually hepatocellular carcinoma (HCC), represents a major health problem in the world. HBV is the prototype member of the hepadnavirus family, which includes several related mammalian viruses also implicated in liver carcinogenesis in the host. Although epidemiological evidence has clearly linked HBV infection with HCC development, the precise role of the virus and the molecular mechanisms of liver cell transformation remain elusive. Here we discuss potential oncogenic strategies of HBV, ranging from indirect mechanisms related to chronic necroinflammatory disease and to the effects of viral gene products on cell proliferation and apoptosis, to direct insertional activation of cellular (onco)genes. Presently, vaccination of high risk populations represents a major way to prevent the development of HBV-related liver cancer.

Entities:  

Mesh:

Year:  1998        PMID: 9755793     DOI: 10.1016/s0753-3322(97)86239-7

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  15 in total

Review 1.  Hepatitis B virus-induced oncogenesis.

Authors:  Joachim Lupberger; Eberhard Hildt
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

2.  Differences in cause-of-death patterns between the native Dutch and persons of Indonesian descent in the Netherlands.

Authors:  Lintje Ho; Vivian Bos; Anton E Kunst
Journal:  Am J Public Health       Date:  2007-07-31       Impact factor: 9.308

3.  Evaluation of transcriptional efficiency of hepatitis B virus covalently closed circular DNA by reverse transcription-PCR combined with the restriction enzyme digestion method.

Authors:  Yu-Chi Chou; King-Song Jeng; Mong-Liang Chen; Hsiao-Hui Liu; Tzu-Ling Liu; Ya-Ling Chen; Yu-Chih Liu; Cheng-po Hu; Chungming Chang
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

4.  The mitogenic function of hepatitis B virus X protein resides within amino acids 51 to 140 and is modulated by N- and C-terminal regulatory regions.

Authors:  Huajie Li; Chia-Yi Chi; Sook Lee; Ourania M Andrisani
Journal:  J Virol       Date:  2006-08-18       Impact factor: 5.103

5.  The hepatitis B virus X protein modulates hepatocyte proliferation pathways to stimulate viral replication.

Authors:  Tricia L Gearhart; Michael J Bouchard
Journal:  J Virol       Date:  2010-01-06       Impact factor: 5.103

6.  Hepatitis B virus X protein activates the p38 mitogen-activated protein kinase pathway in dedifferentiated hepatocytes.

Authors:  Chi Tarn; Lin Zou; Ronald L Hullinger; Ourania M Andrisani
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

7.  Prevalence of a virus similar to human hepatitis B virus in swine.

Authors:  Wengui Li; Ruiping She; Liqiang Liu; Hua You; Jun Yin
Journal:  Virol J       Date:  2010-03-17       Impact factor: 4.099

8.  Pretreatment predictor of response, time to progression, and survival to intraarterial 5-fluorouracil/interferon combination therapy in patients with advanced hepatocellular carcinoma.

Authors:  Kiminori Uka; Hiroshi Aikata; Shintaro Takaki; Daiki Miki; Tomokazu Kawaoka; Soo Cheol Jeong; Shoichi Takahashi; Naoyuki Toyota; Katsuhide Ito; Kazuaki Chayama
Journal:  J Gastroenterol       Date:  2007-10-15       Impact factor: 7.527

9.  Identification and characterization of a novel bipartite nuclear localization signal in the hepatitis B virus polymerase.

Authors:  Joachim Lupberger; Stephanie Schaedler; Alexander Peiran; Eberhard Hildt
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

10.  Gene profiling, biomarkers and pathways characterizing HCV-related hepatocellular carcinoma.

Authors:  Valeria De Giorgi; Alessandro Monaco; Andrea Worchech; Marialina Tornesello; Francesco Izzo; Luigi Buonaguro; Francesco M Marincola; Ena Wang; Franco M Buonaguro
Journal:  J Transl Med       Date:  2009-10-12       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.